Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Mar. 2026,
Manipal Health Enterprises paid₹0 Mil more to buy back shares than it received from issuing new shares.
It received₹55,559 Mil from issuing more debt.
It paid₹0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received₹0 Mil from paying cash dividends to shareholders.
It spent₹5,351 Mil on other financial activities.
In all, Manipal Health Enterprisesearned₹50,208 Mil on financial activities for the
six
months ended in Mar. 2026.
Manipal Health Enterprises (NSE:MANIPALHOS) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Manipal Health Enterprises's issuance of stock for the
six
months ended in Mar. 2026 was ₹0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Manipal Health Enterprises's repurchase of stock for the
six
months ended in Mar. 2026 was ₹0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Manipal Health Enterprises's net issuance of debt for the
six
months ended in Mar. 2026 was ₹55,559 Mil.
Manipal Health Enterprises received₹55,559 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Manipal Health Enterprises's net issuance of preferred for the
six
months ended in Mar. 2026 was ₹0 Mil.
Manipal Health Enterprises paid₹0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Manipal Health Enterprises's cash flow for dividends for the
six
months ended in Mar. 2026 was ₹0 Mil.
Manipal Health Enterprises received₹0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Manipal Health Enterprises's other financing for the
six
months ended in Mar. 2026 was ₹-5,351 Mil.
Manipal Health Enterprises spent₹5,351 Mil on other financial activities.
Manipal Health Enterprises Cash Flow from Financing Related Terms
Manipal Health Enterprises Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises Cash Flow from Financing Chart
Manipal Health Enterprises Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Manipal Health Enterprises's Cash from Financing for the fiscal year that ended in Mar. 2026 is calculated as:
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ₹49,544 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of ₹49,544 Mil mean?
Manipal Health Enterprises (NSE:MANIPALHOS) has a Cash Flow from Financing of ₹49,544 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Manipal Health Enterprises and its competitors.
Is Manipal Health Enterprises' Cash Flow from Financing too high?
Manipal Health Enterprises' current Cash Flow from Financing is ₹49,544 Mil. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' Cash Flow from Financing compare to HCA and THC?
Manipal Health Enterprises' Cash Flow from Financing of ₹49,544 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Manipal Health Enterprises and its competitors. Manipal Health Enterprises's current Cash Flow from Financing is ₹49,544 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current Cash Flow from Financing of ₹49,544 Mil. The current Cash Flow from Financing is ₹49,544 Mil. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current Cash Flow from Financing is ₹49,544 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score
Get the complete analysis for NSE:MANIPALHOS
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANIPALHOS has been successfully added to your 
